Xylem (NYSE:XYL - Get Free Report)'s stock had its "peer perform" rating reissued by research analysts at Wolfe Research in a research report issued on Thursday, Marketbeat reports.
Several other equities analysts also recently commented on the company. Robert W. Baird lowered their price target on Xylem from $175.00 to $154.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Citigroup upgraded shares of Xylem from a "neutral" rating to a "buy" rating and raised their target price for the company from $135.00 to $148.00 in a research note on Monday. Royal Bank of Canada cut their target price on shares of Xylem from $163.00 to $162.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. Stifel Nicolaus lowered their price target on Xylem from $172.00 to $166.00 and set a "buy" rating on the stock in a research report on Wednesday. Finally, TD Cowen cut their price objective on Xylem from $138.00 to $125.00 and set a "hold" rating for the company in a research report on Wednesday, November 6th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $149.91.
Get Our Latest Analysis on XYL
Xylem Stock Down 1.9 %
NYSE XYL traded down $2.31 during trading on Thursday, reaching $121.07. The company's stock had a trading volume of 1,576,237 shares, compared to its average volume of 1,240,983. The company has a current ratio of 1.96, a quick ratio of 1.42 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $29.41 billion, a PE ratio of 36.08, a PEG ratio of 2.37 and a beta of 1.05. Xylem has a 1-year low of $106.52 and a 1-year high of $146.08. The business has a 50-day moving average price of $128.22 and a 200-day moving average price of $132.75.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.11. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The business had revenue of $2.10 billion during the quarter, compared to analyst estimates of $2.17 billion. During the same quarter in the previous year, the business earned $0.99 EPS. Xylem's quarterly revenue was up .2% compared to the same quarter last year. On average, research analysts forecast that Xylem will post 4.23 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Xylem
A number of hedge funds have recently made changes to their positions in XYL. Charles Schwab Investment Management Inc. increased its stake in Xylem by 0.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,345,768 shares of the industrial products company's stock valued at $181,719,000 after acquiring an additional 5,817 shares during the period. Victory Capital Management Inc. lifted its stake in Xylem by 9.3% during the third quarter. Victory Capital Management Inc. now owns 1,627,279 shares of the industrial products company's stock worth $219,731,000 after purchasing an additional 137,883 shares during the period. Groupama Asset Managment boosted its holdings in Xylem by 89.6% during the third quarter. Groupama Asset Managment now owns 16,340 shares of the industrial products company's stock valued at $2,206,000 after purchasing an additional 7,723 shares in the last quarter. BNP Paribas Financial Markets grew its stake in shares of Xylem by 16.5% in the 3rd quarter. BNP Paribas Financial Markets now owns 547,435 shares of the industrial products company's stock valued at $73,920,000 after purchasing an additional 77,639 shares during the period. Finally, Cerity Partners LLC raised its holdings in shares of Xylem by 22.9% in the 3rd quarter. Cerity Partners LLC now owns 115,045 shares of the industrial products company's stock worth $15,534,000 after buying an additional 21,464 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.
About Xylem
(
Get Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.